Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LACTOSE INDIA   MYLAN
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
MYLAN
Dec-18
LACTOSE INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs963,975-   
Low Rs392,188-   
Sales per share (Unadj.) Rs52.31,829.1-  
Earnings per share (Unadj.) Rs1.049.7-  
Cash flow per share (Unadj.) Rs4.7392.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs32.21,978.8-  
Shares outstanding (eoy) m12.59514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 77.0%   
Avg P/E ratio x70.662.0 113.8%  
P/CF ratio (eoy) x14.57.9 184.3%  
Price / Book Value ratio x2.11.6 135.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m8541,585,442 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1220-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m658941,074 0.1%  
Other income Rs m70-   
Total revenues Rs m665941,074 0.1%   
Gross profit Rs m115243,515 0.0%  
Depreciation Rs m47176,206 0.0%   
Interest Rs m6045,262 0.1%   
Profit before tax Rs m1522,047 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3-3,507 -0.1%   
Profit after tax Rs m1225,554 0.0%  
Gross profit margin %17.425.9 67.3%  
Effective tax rate %17.5-15.9 -109.8%   
Net profit margin %1.82.7 67.7%  
BALANCE SHEET DATA
Current assets Rs m375525,495 0.1%   
Current liabilities Rs m266383,144 0.1%   
Net working cap to sales %16.615.1 109.8%  
Current ratio x1.41.4 102.9%  
Inventory Days Days4684 54.5%  
Debtors Days Days69393 742.7%  
Net fixed assets Rs m643182,553 0.4%   
Share capital Rs m126501 25.1%   
"Free" reserves Rs m2800-   
Net worth Rs m4061,018,070 0.0%   
Long term debt Rs m3301,098,825 0.0%   
Total assets Rs m1,0182,730,861 0.0%  
Interest coverage x1.21.5 83.6%   
Debt to equity ratio x0.81.1 75.5%  
Sales to assets ratio x0.60.3 187.6%   
Return on assets %7.12.6 274.5%  
Return on equity %3.02.5 118.7%  
Return on capital %10.23.2 320.5%  
Exports to sales %00-   
Imports to sales %31.30-   
Net fx Rs m-1050-   
CASH FLOW
From Operations Rs m81195,555 0.0%  
From Investments Rs m-10-101,081 0.0%  
From Financial Activity Rs m-84-91,101 0.1%  
Net Cashflow Rs m-131,620 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare LACTOSE INDIA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare LACTOSE INDIA With: TORRENT PHARMA  PARENT.DRUGS  LAURUS LABS   WOCKHARDT  BLISS GVS PHARMA  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.